irgd peptide iRGD tumor-penetrating peptide-modified oncolytic adenovirus - Enhancing tumor Targeted Therapy The role ofiRGD peptidein Advanced drug Delivery Systems iRGD therapy effectively converted the immunosuppressive PDAC microenvironment The Promise of iRGD Peptide: Revolutionizing Cancer Therapy and Drug Delivery

Enhancing tumor Targeted Therapy The role ofiRGD peptidein Advanced drug Delivery Systems The field of oncology is constantly seeking innovative solutions to overcome the challenges of cancer treatment, particularly in effectively delivering therapeutic agents to tumor sites. Emerging research highlights the significant potential of the iRGD peptide, a novel peptide that acts as a potent tumor-penetrating enhancer. This internalizing arginine-glycine-aspartic acid (iRGD) peptide is proving to be a game-changer in enhancing drug delivery and improving therapeutic outcomes in various cancers.

Understanding the iRGD Peptide: Structure and Mechanism

The iRGD peptide, also known by its sequence c(CRGDKGPDC) or CRGDKGPDC, is a nine-amino acid cyclic peptide. Its unique structure and function allow it to effectively target and penetrate tumor tissues. The mechanism of action for the iRGD peptide involves a dual binding strategy.2025年4月21日—iRGD therapy effectively converted the immunosuppressive PDAC microenvironmentto an immune-favorable state by enhancing beneficial T cell ... Firstly, it binds to αv integrins, specifically αvβ3 and αvβ5 integrins, which are often overexpressed on tumor cells and tumor vasculature.2025年4月21日—iRGD therapy effectively converted the immunosuppressive PDAC microenvironmentto an immune-favorable state by enhancing beneficial T cell ... This initial binding is crucial for initiating the internalization process. Following this, the iRGD peptide undergoes proteolytic cleavage, which then facilitates its interaction with neuropilin-1 receptors.作者：D Nikitovic·2024·被引用次数：52—iRGD is a tumor-penetrating peptidethat could be crucial in treating cancer. Its unique ability to penetrate tumor tissues deeply establishes it as an ... This sequential binding and cleavage process is fundamental to its ability to trigger tissue penetration.iRGD Peptide as a Tumor-Penetrating Enhancer for ...

Key Properties and Advantages of iRGD Peptides

The iRGD peptides possess several remarkable properties that make them highly valuable in cancer therapy and drug delivery:

* Tumor Penetration: A primary advantage of the iRGD peptide is its exceptional ability to penetrate deep into tumor tissues. This characteristic is vital because many solid tumors have a dense and poorly vascularized structure, hindering the delivery of conventional therapeuticsiRGD peptide (c(CRGDKGPDC)). The iRGD is a tumor-penetrating peptide that effectively overcomes this barrier.作者：Y Pan·2024·被引用次数：11—We proved thatαPD-1-(iRGD)2 can enhance the therapeutic potential for cancer treatmentby simultaneously engaging T cells and tumor cells, ...

* Tumor Targeting: The specific binding to upregulated αv integrins and neuropilin-1 receptors on tumor cells and their surrounding environment allows for targeted delivery, minimizing off-target effects and enhancing therapeutic efficacy. This iRGD-mediated tumor targeting is a cornerstone of its application.

* Enhanced Permeability: The iRGD peptide enhances the permeability of tumor vessels, creating more accessible pathways for therapeutic agents to enter the tumor microenvironment. This property is critical for improving the distribution of drugs within the tumor.

* Versatility in Drug Delivery Systems: The iRGD peptide can be readily synthesized and incorporated into various drug delivery systemsiRGD is a tumor-penetrating peptidethat can be used as a permeation tumor enhancer and a ligand for targeting cancer. It specifically binds to the integrin .... For instance, an iRGD peptide-modified lipid-polymer hybrid nanosystem has been developed to co-load multiple therapeutic agents. Furthermore, iRGD tumor-penetrating peptide-modified oncolytic adenovirus has demonstrated enhanced tumor transduction and antitumor efficacy.

* Improved Penetration: Compared to traditional peptides, the iRGD peptide exhibits significantly improved penetration, making it a superior choice for delivering agents deep into extravascular tumor tissue.iRGD tumor-penetrating peptide-modified nano-delivery ... This is highlighted by studies on iRGD peptide 1 TFA, a prototypic tumor-specific tissue-penetrating peptide.

Applications in Cancer Therapy and Imaging

The unique capabilities of the iRGD peptide have opened up exciting avenues for its application in cancer treatment and diagnostics:

* Enhanced Anti-Cancer Drug Delivery: The iRGD peptide acts as a prominent enhancer that enables anti-cancer drugs to penetrate tumorigenic blood vessels. It facilitates the delivery of agents, including chemotherapeutic drugs like paclitaxel, into tumors, thereby increasing their local concentration and efficacy.

* Cancer Imaging: The tumor-homing and penetrating nature of the iRGD peptide makes it an excellent candidate for cancer imagingCo-administration of iRGD with peptide HPRP-A1 ... - Nature. Researchers have harnessed the iRGD peptide in conjunction with near-infrared fluorescent (NIRF) tracers to enhance the molecular probe's ability to actively target tumors.

* Combination Therapies: Studies are exploring the synergistic effects of the iRGD peptide in combination with other therapeutic modalities. For example, αPD-1-(iRGD)2 has shown potential to enhance therapeutic outcomes for cancer treatment by simultaneously engaging T cells and tumor cells.iRGD peptide是一种由9 个氨基酸组成的环肽，先与av integrins 结合，随后酶解产生CRGDK/R 与神经纤毛蛋白-1 (neuropilin-1) 相互作用，从而促进药物的组织渗透，具有靶向肿瘤 ... Additionally, iRGD therapy effectively converted the immunosuppressive PDAC microenvironment to an immune-favorable state.

* Nanocarrier Modification: The iRGD peptide has been conjugated to various nanocarriers to improve their tumor-targeting and penetration capabilities作者：C Hu·2018·被引用次数：48—Co-administration ofiRGDand HPRP-A1 exhibited stronger anticancer activity and tumor specificity against A549 non-small cell lung cancer cells with NRP-1 .... An example is an iRGD peptide-conjugated heparin nanocarrier that exhibits excellent biodegradation due to its heparin biopolymer frame and biocompatibilityiRGD peptidesare a class of 9-amino acid cyclic peptides containing an RGD sequence, which undergo internalization as discussed below..

Future Directions and Research

The ongoing research into the iRGD peptide continues to unveil its full therapeutic potential.iRGD Peptide Scientists are investigating its role in overcoming drug resistance, modulating the tumor microenvironment, and developing novel therapeutic strategies. The ability of the iRGD peptide to facilitate deep tumor penetration and enhance the delivery of therapeutic payloads positions it as a critical component in the future of cancer therapy2025年4月21日—iRGD therapy effectively converted the immunosuppressive PDAC microenvironmentto an immune-favorable state by enhancing beneficial T cell .... Further research into iRGD-mediated tumor targeting and the development of advanced delivery systems incorporating this peptide promises to bring more effective and less invasive treatments to patients. The iRGD peptide represents a significant advancement, offering hope for improved outcomes in the fight against cancer.